Online intake preparation

Online peptide therapy intake checklist: what to prepare

A patient-safe checklist for preparing an online peptide therapy intake, including goals, medications, labs, pharmacy labels, symptoms, costs, and follow-up questions.

Intake facts to gather

1

Define the main goal first: weight management, energy, recovery, skin or hair, sexual health, medication access, side effects, or a care transfer.

2

List all medicines and supplements with dose, route, timing, recent changes, allergies, prior side effects, and the reason each product is used.

3

Gather relevant records such as labs, vitals, diagnoses, pregnancy or fertility context, surgery dates, pharmacy labels, refill history, and photos when appropriate.

4

Ask product-specific questions for GLP-1s, sermorelin, PT-141, NAD+, glutathione, GHK-Cu, methylene blue, or any compounded prescription being considered.

5

Confirm what happens after intake: clinician decision, possible records or labs, pharmacy source, label checks, cost, shipping, follow-up, refill timing, and urgent pathways.

Direct answer

Before an online peptide therapy intake, prepare your goals, health history, medication and supplement list, allergies, pregnancy or surgery context, recent labs or vitals, prior pharmacy labels, side effects, and cost or refill questions. The intake should support licensed clinician review, not automatic approval or no-prescription peptide checkout.

Start with the medical question

A good intake is more than a product request

Online peptide therapy intake should help a clinician understand the person, the goal, and the risk profile before deciding whether treatment is appropriate. Peptide12-listed options include compounded semaglutide, compounded tirzepatide, Wegovy, Ozempic, Zepbound, Mounjaro, sermorelin, PT-141/bremelanotide, NAD+, glutathione, GHK-Cu topical foam, and low-dose oral methylene blue; each raises different screening questions.

  • Write down what success would mean in practical terms, such as weight trend, appetite, fatigue, recovery, skin/scalp tolerance, sexual-health concerns, or medication access—not a guaranteed outcome.
  • Include diagnoses, recent symptoms, allergies, pregnancy or fertility plans, surgery or anesthesia timing, and whether primary-care or specialist clinicians are already involved.
  • If the goal is vague or symptoms are new, worsening, severe, or unexplained, the safer next step may be records, labs, urgent care, primary care, or specialist review rather than starting peptide therapy online.

Medication and record review

Bring the details that change prescribing safety

The medication list is often the highest-value part of an online intake. Prescription medicines, over-the-counter products, vitamins, herbs, nootropics, protein or creatine products, alcohol, cannabis, and prior peptide use can affect side effects, interactions, refill decisions, expectations, and whether a clinician needs more information before prescribing.

  • For GLP-1 discussions, note diabetes medicines, GI symptoms, dehydration risk, kidney history, gallbladder or pancreas history, pregnancy planning, and branded versus compounded access questions.
  • For PT-141, methylene blue, sermorelin, NAD+, glutathione, or GHK-Cu, note blood pressure, cardiovascular history, psychiatric or serotonergic medicines, G6PD history when relevant, labs, route-specific irritation, and product-quality questions.
  • Prior labels, pharmacy names, strengths, routes, beyond-use dates, refill dates, adverse reactions, and storage or shipping issues can prevent unsafe assumptions during a transfer or restart.

After the form

The intake should lead to a clear next step, not automatic checkout

A responsible online clinic can approve, decline, delay, redirect, or request more information after intake. If medication is prescribed, the next step should include a clear pharmacy or brand channel, label expectations, storage instructions, cost details, side-effect guidance, follow-up access, and refill rules. Compounded prescriptions, when used, should be described as individualized prescriptions, not FDA-approved finished drug products.

  • Ask who reviews the intake, how follow-up questions are handled, whether video, phone, labs, or records may be requested, and what symptoms should bypass portal messaging.
  • Avoid clinics that treat a short questionnaire as guaranteed approval, hide pharmacy sourcing, sell research-use products for human use, or provide generic dosing and stacking charts.
  • Save your intake summary, clinician instructions, pharmacy labels, receipts, and follow-up messages so future refills, primary-care visits, and clinic transfers use the same facts.

Patient safety checklist

What to gather before an online peptide therapy intake

These points are educational and do not replace medical advice. A licensed clinician should review individual history, medications, risks, and state-specific availability before treatment.

What is my main goal, and which symptom or outcome should a clinician evaluate first?

What prescription medicines, OTC products, supplements, alcohol, cannabis, hormones, or prior peptide products do I currently use?

Do I have allergies, prior injectable reactions, asthma, sulfite or dye sensitivity, or medication side effects that changed a past plan?

Do pregnancy, breastfeeding, fertility treatment, contraception, surgery, anesthesia, or a new diagnosis affect timing?

What recent labs, vitals, weight trends, glucose readings, blood-pressure readings, pharmacy labels, portal records, or specialist notes can I upload?

Which product-specific cautions apply to GLP-1s, sermorelin, PT-141, NAD+, glutathione, GHK-Cu, methylene blue, or compounded prescriptions?

What should happen if the clinician needs more records, labs, a live visit, primary-care coordination, urgent care, or specialist input?

Can I see the full cost, pharmacy or brand source, shipping plan, refill timeline, cancellation rules, and follow-up pathway before paying?

FAQs

Short answers for patients

What should I prepare for an online peptide therapy intake?

Prepare your goals, diagnoses, medication and supplement list, allergies, pregnancy or surgery context, recent labs or vitals, pharmacy labels, past side effects, refill history, and questions about cost, pharmacy source, follow-up, and safety.

Can an online intake guarantee peptide therapy approval?

No. Intake information supports clinician review, but approval, product choice, dosing, labs, pharmacy availability, and follow-up depend on patient-specific evaluation and applicable rules. A clinic should be willing to decline, delay, or redirect care when needed.

Do I need labs before a peptide therapy intake?

Not every intake requires labs before the first review, but labs may be requested depending on the product, goal, medical history, medications, symptoms, or clinician judgment. Do not self-order or interpret labs as a substitute for medical advice.

Should I include supplements on the intake form?

Yes. Vitamins, herbs, nootropics, protein products, creatine, sleep aids, caffeine products, and other supplements can affect side effects, interactions, lab interpretation, and expectations. Include brand, dose, frequency, and recent changes when possible.

What is a red flag in an online peptide therapy questionnaire?

Red flags include guaranteed approval, no prescription requirement, research-use products marketed for people, hidden clinician credentials, hidden pharmacy sourcing, automatic dosing charts, no side-effect guidance, and pressure to buy before medical review.

Are compounded peptide prescriptions FDA-approved?

Compounded prescriptions are not FDA-approved finished drug products. They may be prepared for an individual patient when clinically appropriate and allowed under applicable rules, but they should not be described as generic versions of FDA-approved brand products.